Revigro Pharmaceutical Private Limited - Company Profile

It is a pharma private limited company based in Milk Cly Mumbai, Maharashtra, India, established in 2018.
2018 Milk Cly Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Revigro Pharmaceutical Private Limited

Revigro Pharmaceutical Private Limited, a active private limited company, was established on 21 August 2018 in Milk Cly Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24111MH2018PTC312958. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.40 M and a paid-up capital of ₹0.10 M.

Its leadership includes Anil Kedarnath Yadav (Director), Gyan Anil Yadav (Director). Past directors included Anil Yadav, Gyan Anil Yadav. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 159 B Wing Orchard, Road Mall, Goregaon East, Royal Palms Survey No. 169 Aarey, Milk Cly Mumbai, Maharashtra, 400065.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24111MH2018PTC312958

  • Registration Number

    312958

  • Incorporation Date

    21 August 2018

  • Authorized Capital

    ₹0.40 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.40 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 3.19%
  • Profit Growth **** 343.60%
  • Ebitda **** -2.44%
  • Net Worth 35.18%
  • Total Assets -18.49%
Company report

Revigro Pharmaceutical Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Revigro Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Revigro Pharmaceutical Private Limited?
Current Directors
Name Designation Appointment Date Status
Anil Kedarnath Yadav Director 21 Aug 2018 Current
Gyan Anil Yadav Director 02 Feb 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 20 Feb 2024 Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Revigro Pharmaceutical.

Revigro Pharmaceutical Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.19% increase. The company also saw a substantial improvement in profitability, with a 343.6% increase in profit. The company's net worth Soared by an impressive increase of 35.18%.

Revigro Pharmaceutical revenue growth over time
Revigro Pharmaceutical profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 3.19%
*******
*******
*******
*******
Revenue from Operations
*******
 3.19%
*******
*******
*******
*******
Total Assets
*******
 -18.49%
*******
*******
*******
*******
Profit or Loss
*******
 343.60%
*******
*******
*******
*******
Net Worth
*******
 35.18%
*******
*******
*******
*******
EBITDA
*******
 -2.44%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Revigro Pharmaceutical?

Unlock access to Revigro Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Revigro Pharmaceutical?

Unlock and access historical data on people associated with Revigro Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Revigro Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Revigro Pharmaceutical's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Revigro Pharmaceutical
Recent Activity within the Organization
  • Annual General Meeting

    Revigro Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Revigro Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    Gyan Anil Yadav was appointed as a Director was appointed as a Director on 02 Feb 2024 & has been associated with this company since 2 years 11 days . was recorded as a recent event.

  • Director Appointment

    Progress on Anil Kedarnath Yadav was appointed as a Director was appointed as a Director on 21 Aug 2018 & has been associated with this company since 7 years 5 months . was documented.

  • Company Incorporation

    Revigro Pharmaceutical Private Limited was registered on 21 Aug 2018 with Roc Mumbai & aged 7 years 5 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Revigro Pharmaceutical Private Limited?

The CIN of Revigro Pharmaceutical Private Limited is U24111MH2018PTC312958.

Where is Revigro Pharmaceutical Private Limited headquartered?

Revigro Pharmaceutical Private Limited is headquartered at 159 B Wing Orchard, Road Mall, Goregaon East, Royal Palms Survey No. 169 Aarey, Milk Cly Mumbai, Maharashtra, 400065.

When was Revigro Pharmaceutical Private Limited incorporated?

Revigro Pharmaceutical Private Limited was incorporated on 21 August 2018.

Who are the current directors of Revigro Pharmaceutical Private Limited?

The current directors of Revigro Pharmaceutical Private Limited are

What is the primary industry of Revigro Pharmaceutical Private Limited?

The primary industry of Revigro Pharmaceutical Private Limited is Trade.

Is Revigro Pharmaceutical Private Limited a listed company?

Revigro Pharmaceutical Private Limited is unlisted.

What is the capital structure of Revigro Pharmaceutical Private Limited?

The authorized capital of Revigro Pharmaceutical Private Limited is ₹0.40 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available